Company Profile
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
Latest News
How Lisa Su Has Positioned AMD to Be a Big AI Winner and Why the Stock Is a Buy
Share buybacks in Ericsson during the period July 20 - July 24, 2026
OTLK Stock Jumps Overnight After FDA Approval Of Wet AMD Drug — Analysts See Nearly 300% Upside
Temenos Named One of World’s Top Fintech Companies by CNBC
Emerging markets stare at inflation risks as powerful El Niño looms
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Website | https://www.torrentpharma.com |
| Audit Risk | 2 |
| Board Risk | 3 |
| Overall Risk | 3 |
| Market Cap | 1.92T |
| Trailing P/E | 78.71 |
| Forward P/E | 53.61 |
| Dividend Rate | 38 |
| Dividend Yield | 0.77% |
| Trailing Annual Div. Rate | 38 |
| Trailing Annual Div. Yield | 0.77% |
| Trailing EPS | 64 |
| Forward EPS | 93.97 |
| Book Value | 247.85 |
| Price-to-Book | 20.32 |
| Enterprise-to-Revenue | 13.58 |
| Enterprise-to-EBITDA | 42.21 |
| Ex-Dividend Date | 05/29/2026 |
| Earnings Date | 07/30/2026 |
| Earnings Call Date | 07/30/2026 |
| Earnings Average | 14.93 |
| Earnings Low | 11.7 |
| Earnings High | 17.1 |
| Revenue Average | 47.17B |
| Revenue Low | 43.55B |
| Revenue High | 48.32B |